A detailed history of National Bank Of Canada transactions in Nkarta, Inc. stock. As of the latest transaction made, National Bank Of Canada holds 299 shares of NKTX stock, worth $699. This represents 0.0% of its overall portfolio holdings.

Number of Shares
299
Previous 299 -0.0%
Holding current value
$699
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$4.52 - $8.0 $4 - $8
-1 Reduced 0.33%
299 $1,000
Q4 2021

Jan 24, 2022

BUY
$12.79 - $26.88 $3,836 - $8,064
300 New
300 $5,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $114M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.